250 related articles for article (PubMed ID: 21184787)
21. Hepatitis C virus inhibits intracellular interferon alpha expression in human hepatic cell lines.
Zhang T; Lin RT; Li Y; Douglas SD; Maxcey C; Ho C; Lai JP; Wang YJ; Wan Q; Ho WZ
Hepatology; 2005 Oct; 42(4):819-27. PubMed ID: 16175599
[TBL] [Abstract][Full Text] [Related]
22. A preliminary analysis of hepatitis C virus in pancreatic islet cells.
Blackard JT; Kong L; Lombardi A; Homann D; Hammerstad SS; Tomer Y
Virol J; 2017 Dec; 14(1):237. PubMed ID: 29258547
[TBL] [Abstract][Full Text] [Related]
23. Hepatitis C virus triggers apoptosis of a newly developed hepatoma cell line through antiviral defense system.
Zhu H; Dong H; Eksioglu E; Hemming A; Cao M; Crawford JM; Nelson DR; Liu C
Gastroenterology; 2007 Nov; 133(5):1649-59. PubMed ID: 17983809
[TBL] [Abstract][Full Text] [Related]
24. Constitutive androstane receptor transactivates the hepatic expression of mouse Dhcr24 and human DHCR24 encoding a cholesterogenic enzyme 24-dehydrocholesterol reductase.
Yoshinari K; Ohno H; Benoki S; Yamazoe Y
Toxicol Lett; 2012 Jan; 208(2):185-91. PubMed ID: 22101211
[TBL] [Abstract][Full Text] [Related]
25. Desmosterol and DHCR24: unexpected new directions for a terminal step in cholesterol synthesis.
Zerenturk EJ; Sharpe LJ; Ikonen E; Brown AJ
Prog Lipid Res; 2013 Oct; 52(4):666-80. PubMed ID: 24095826
[TBL] [Abstract][Full Text] [Related]
26. Serum DHCR24 Auto-antibody as a new Biomarker for Progression of Hepatitis C.
Ezzikouri S; Kimura K; Sunagozaka H; Kaneko S; Inoue K; Nishimura T; Hishima T; Kohara M; Tsukiyama-Kohara K
EBioMedicine; 2015 Jun; 2(6):604-12. PubMed ID: 26288822
[TBL] [Abstract][Full Text] [Related]
27. Development of mouse hepatocyte lines permissive for hepatitis C virus (HCV).
Aly HH; Oshiumi H; Shime H; Matsumoto M; Wakita T; Shimotohno K; Seya T
PLoS One; 2011; 6(6):e21284. PubMed ID: 21731692
[TBL] [Abstract][Full Text] [Related]
28. Targeting cellular squalene synthase, an enzyme essential for cholesterol biosynthesis, is a potential antiviral strategy against hepatitis C virus.
Saito K; Shirasago Y; Suzuki T; Aizaki H; Hanada K; Wakita T; Nishijima M; Fukasawa M
J Virol; 2015 Feb; 89(4):2220-32. PubMed ID: 25473062
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of DHCR24 increases the cisplatin-induced damage to cochlear hair cells in vitro.
Tian KY; Chang HM; Wang J; Qi MH; Wang WL; Qiu Y; Liang K; Chen FQ; Zha DJ; Qiu JH
Neurosci Lett; 2019 Jul; 706():99-104. PubMed ID: 31091460
[TBL] [Abstract][Full Text] [Related]
30. Genkwadaphnin inhibits growth and invasion in hepatocellular carcinoma by blocking DHCR24-mediated cholesterol biosynthesis and lipid rafts formation.
Wu J; Guo L; Qiu X; Ren Y; Li F; Cui W; Song S
Br J Cancer; 2020 Nov; 123(11):1673-1685. PubMed ID: 32958824
[TBL] [Abstract][Full Text] [Related]
31. Negative regulation of intracellular hepatitis C virus replication by interferon regulatory factor 3.
Yamashiro T; Sakamoto N; Kurosaki M; Kanazawa N; Tanabe Y; Nakagawa M; Chen CH; Itsui Y; Koyama T; Takeda Y; Maekawa S; Enomoto N; Sakugawa H; Watanabe M
J Gastroenterol; 2006 Aug; 41(8):750-7. PubMed ID: 16988763
[TBL] [Abstract][Full Text] [Related]
32. Thromboxane A2 synthase inhibitors prevent production of infectious hepatitis C virus in mice with humanized livers.
Abe Y; Aly HH; Hiraga N; Imamura M; Wakita T; Shimotohno K; Chayama K; Hijikata M
Gastroenterology; 2013 Sep; 145(3):658-67.e11. PubMed ID: 23684750
[TBL] [Abstract][Full Text] [Related]
33. Serine palmitoyltransferase inhibitor suppresses HCV replication in a mouse model.
Umehara T; Sudoh M; Yasui F; Matsuda C; Hayashi Y; Chayama K; Kohara M
Biochem Biophys Res Commun; 2006 Jul; 346(1):67-73. PubMed ID: 16750511
[TBL] [Abstract][Full Text] [Related]
34. Hepatitis B virus and hepatitis C virus interaction in Huh-7 cells.
Eyre NS; Phillips RJ; Bowden S; Yip E; Dewar B; Locarnini SA; Beard MR
J Hepatol; 2009 Sep; 51(3):446-57. PubMed ID: 19596477
[TBL] [Abstract][Full Text] [Related]
35. Primary cultures of human hepatocytes isolated from hepatitis C virus-infected cirrhotic livers as a model to study hepatitis C infection.
Raymond VA; Selliah S; Ethier C; Houle R; Jouan L; Maniere T; Lamarre D; Willems B; Bilodeau M
Liver Int; 2009 Jul; 29(6):942-9. PubMed ID: 19302183
[TBL] [Abstract][Full Text] [Related]
36. MEAN inhibits hepatitis C virus replication by interfering with a polypyrimidine tract-binding protein.
Xue J; Liu Y; Yang Y; Wu S; Hu Y; Yang F; Zhou X; Wang J; Chen F; Zheng M; Zhu H; Chen Z
J Cell Mol Med; 2016 Jul; 20(7):1255-65. PubMed ID: 26929148
[TBL] [Abstract][Full Text] [Related]
37. Relationships between hepatitis C virus replication and CXCL-8 production in vitro.
Koo BC; McPoland P; Wagoner JP; Kane OJ; Lohmann V; Polyak SJ
J Virol; 2006 Aug; 80(16):7885-93. PubMed ID: 16873245
[TBL] [Abstract][Full Text] [Related]
38. [Inhibition of hepatitis C virus replication by mycophenolic acid in hepatocytes].
Chen H; Ye L; Su JM; Li Y; Zeng JR; Huo WZ
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2013 Feb; 27(1):35-8. PubMed ID: 23855126
[TBL] [Abstract][Full Text] [Related]
39. Infection of Hepatocytes With HCV Increases Cell Surface Levels of Heparan Sulfate Proteoglycans, Uptake of Cholesterol and Lipoprotein, and Virus Entry by Up-regulating SMAD6 and SMAD7.
Zhang F; Sodroski C; Cha H; Li Q; Liang TJ
Gastroenterology; 2017 Jan; 152(1):257-270.e7. PubMed ID: 27693511
[TBL] [Abstract][Full Text] [Related]
40. A natural small molecule inhibitor corilagin blocks HCV replication and modulates oxidative stress to reduce liver damage.
Reddy BU; Mullick R; Kumar A; Sharma G; Bag P; Roy CL; Sudha G; Tandon H; Dave P; Shukla A; Srinivasan P; Nandhitha M; Srinivasan N; Das S
Antiviral Res; 2018 Feb; 150():47-59. PubMed ID: 29224736
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
